Immune maintenance in glaucoma: boosting the body's own neuroprotective potential

Area of Science:

• Ophthalmology
• Neuroimmunology
• Neurodegeneration

Background:

• Glaucoma is a progressive neurodegenerative disorder causing retinal ganglion cell death and optic nerve damage.
• Traditionally linked to high intraocular pressure, glaucoma damage can persist even after addressing primary risk factors.
• Neuroprotection strategies aim to shield tissues from ongoing glaucomatous damage.

Purpose of the Study:

• To investigate the role of the immune system in protecting the optic nerve and retina during glaucoma.
• To explore the potential of immune system modulation as a therapeutic strategy for glaucoma.

Main Methods:

• Analysis of the immune system's involvement in glaucoma pathogenesis.
• Evaluation of innate and adaptive immune cell recruitment in the optic nerve and retina.
• Conceptualization of therapeutic vaccination strategies.

Main Results:

• The immune system plays a crucial role in the optic nerve and retina's resilience to glaucoma.
• Innate and adaptive immune cells collaborate to form a protective niche, halting disease progression.
• Spontaneous immune responses may be insufficient, highlighting the need for enhancement.

Conclusions:

• The immune system is a key factor in glaucoma resilience and offers a potential therapeutic target.
• Therapeutic vaccination, by boosting immune responses, could be a viable treatment for glaucoma.
• This immune-centric perspective necessitates new research challenges and therapeutic approaches in glaucoma management.